Showing results (81-90 of 146) with videos related to
Sort By:
Pageof 15
Headache|July 1, 1989
Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175)B G McCarthy, S J PeroutkaBiochemical Pharmacology|June 15, 1986
Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT)J R Schlegel, S J PeroutkaBrain Research|December 8, 1987
Identification of 5-hydroxytryptamine binding site subtypes in rat spinal cordJ C Huang, S J PeroutkaNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1988
Subjective effects of 3,4-methylenedioxymethamphetamine in recreational usersS J Peroutka, H Newman, H HarrisNeurology|July 1, 1997
Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI allelesS J Peroutka, T Wilhoit, K JonesHeadache|July 1, 1993
Wolff Award presentation 1993. Anti-migraine drug interactions with cloned human 5-hydroxytryptamine1 receptor subtypesS J Peroutka, S Havlik, D OksenbergNeuropharmacology|June 1, 1990
In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pigA J Sleight, A Cervenka, S J PeroutkaExperimental Neurology|May 1, 1987
Modulation of postdecapitation convulsions in rats by alpha-adrenergic and 5-hydroxytryptamine1A agentsS J Peroutka, D A Gonzales, M ShapiroThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1986
Canine basilar artery contractions mediated by 5-hydroxytryptamine1A receptorsS J Peroutka, S Huang, G S AllenEuropean Journal of Pharmacology|September 1, 1988
5-Hydroxytryptamine1A receptors are linked to a Gi-adenylate cyclase complex in rat hippocampusM A Harrington, D Oksenberg, S J PeroutkaPageof 15